Controversies in prostate cancer screening: Analogies to the early lung cancer screening debate

JAMA

Volumn 276, Issue 24, 1996, Pages 1976-1979

  Collins, Mary McNaughton ^a   Barry, Michael J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CANCER STAGING; EARLY CANCER; EARLY DIAGNOSIS; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RISK ASSESSMENT;

EID: 0030469260     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.276.24.1976     Document Type: Article

References (73)

1. Andriole GL. The case for prostate cancer screening. Semin Urol. 1993;11:50-53.
2. Partin AW, Oesterling JE. The clinical usefulness of prostate specific antigen: update 1994. J Urol. 1994;152:1358-1368.
3. Benoit RM, Naslund MJ. An economic rationale for prostate cancer screening. Urology. 1994;44: 795-803.
4. Mettlin C, Jones G, Ayerett H, Gusberg SB, Murphy GP. Defining and updating the American Cancer Society guidelines for the cancer-related checkup: prostate and endometrial cancers. CA Cancer J Clin. 1993;43:42-47.
5. Miller AB. What is the role of early detection and screening in cancer control? J Public Health-Policy. 1993;14:403-412.
6. Krahn MD, Mahoney JE, Eckman MH, Trachtenberg J, Pauker SG, Detsky AS. Screening for prostate cancer a decision-analytic view. JAMA. 1994;272:773-780.
7. Woolf SH. Public health perspective: the health policy implications of screening for prostate cancer. J Urol 1994;152:1685-1688.
8. Adami HO, Baron JA, Rothman KJ. Ethics of a prostate cancer screening trial. Lancet. 1994;343: 958-960.
9. Sackett DL, Holland WW. Controversy in the detection of disease. Lancet. 1975;2:357-359.
10. Eddy DM. Three battles to watch in the 1990s. JAMA. 1993;270:520-526.
11. Sackett DL, Haynes RB, Guyatt GH, Tugwell P. Clinical Epidemiology: A Basic Science for Clinical Medicine. Boston, Mass: Little Brown & Co Inc; 1991:153-170.
12. Catalona WJ, Smith DS, Eatliff TL, et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med. 1991;324:1156-1161.
13. Walsh PC. Why make an early diagnosis of prostate cancer? J Urol. 1992;147:853-854.
14. Scardino PT. Afterword: the perspective of a prostate cancer doctor. In: Martin W. My Prostate and Me. New York, NY: Cadell & Davies; 1994: 209-235.
15. Benoit RM, Naslund MJ. Detection of latent prostate cancer from routine screening: comparison with breast cancer screening. Urology. 1995; 46:533-537.
16. Benoit RM, Naslund MJ. An economic rationale for prostate cancer screening. Urology. 1994;44: 795-803.
17. Fletcher SW, Black W, Harris R, Rimer BK, Shapiro S. Report of the International Workshop on Screening for Breast Cancer. J Natl Cancer Inst. 1993;85:1644-1656.
18. Boucot KR. Mass surveys in case-finding techniques for pulmonary neoplasms. J Am Med Worn Assoc. 1948;3:485-492.
19. Overholt RH. Cancer detected in surveys. Am Rev Tuberc. 1950;62:491-500.
20. Victor AB. The early diagnosis of primary lung cancer. Dis Chest. 1955;27:389-409.
21. Boucot KR, Sokoloff MJ. Is survey cancer of the lung curable? Dis Chest. 1955;27:369-388.
22. Boucot KR, Horie U, Sokoloff MJ. Survival in lung cancer. N Engl J Med. 1959;60:742-746.
23. Overholt RH, Woods FM. Early diagnosis and treatment of cancer of the lung. N Engl J Med. 1951;245:555-559.
24. Bean IW. Practitioner's responsibility in cancer detection. CA Cancer J Clin. 1967;17:215-218.
25. Scamman CL. Follow-up study of lung cancer suspects in a mass chest x-ray survey. N Engl J Med. 1951;244:541-544.
26. Berlin NI, Buncher CR, Fontana RS, Frost JK, Melamed MR. The National Cancer Institute Cooperative Early Lung Cancer Detection program. Am Rev Respir Dis. 1984;130:545-549.
27. Taylor WF, Fontana RS, Uhlenhopp MA, Davis CS. Some results of screening for early lung cancer. Cancer. 1981;47:1114-1120.
28. Fontana RS, Sanderson DR, Woolner LB, et al. Screening for lung cancer: a critique of the Mayo Lung Project. Cancer. 1991;67:1155-1164.
29. ACS Workshop and Organizing Committee. Summary of recommendations for early detection. Cancer. 1974;33(suppl):1759-1761.
30. Berlin NI. Summary and recommendations of the workshop on lung cancer. Cancer. 1974;33(suppl): 1744-1746.
31. Fontana RS, Sanderson DR, Woolner LB, et al. The Mayo Lung Project for early detection and localization of bronchogenic carcinoma: a status report. Chest. 1975;67:511-522.
32. Woolner LB, Fontana RS, Sanderson DR, et al. Mayo Lung Project: evaluation of lung cancer screening through December 1979. Mayo Clin Proc. 1981;56:544-555.
33. National Cancer Institute. Mass Screening for Lung Cancer: NCI Consensus Conference, September 18-20, 1978. Bethesda, Md: National Cancer Institutes; 1978:32-34.
34. American Cancer Society. Guidelines for the cancer-related check-up. CA Cancer J Clin. 1980; 30:199-207.
35. Frost JK, Ball WC, Levin ML, et al. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study. Am Rev Respir Dis. 1984;130:549-554.
36. Flehinger BJ, Melamed MR, Zaman MB, Heelan RT, Perchick WB, Martini N. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Memorial Sloan-Kettering study. Am Rev Respir Dis. 1984;130:555-560.
37. Fontana RS, Sanderson DR, Taylor WF, et al. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Mayo Clinic study. Am Rev Respir Dis. 1984; 130:561-565.
38. Early Lung Cancer Cooperative Study. Early lung cancer detection: summary and conclusions. Am Rev Respir Dis. 1984;130:565-570.
39. Melamed MR, Flehinger BJ, Zaman MB, Heelan RT, Perchick WA, Martini N. Screening for early lung cancer: results of Memorial Sloan-Kettering study in New York. Chest. 1984;86:44-53.
40. Tockman MS. Survival and mortality from lung cancer in a screened population: the Johns Hopkins Study. Chest 1986;89(suppl):324S-325S.
41. Fontana RS, Sanderson Dr, Woolner LB, Taylor WF, Miller WE, Muhm JR. Lung cancer screening: the Mayo program. J Occup Med. 1986;28:746-750.
42. Eddy DM. Screening for lung cancer. Ann Intern Med. 1989;111:232-237.
43. Reich JM. Dysutility of screening chest roentgenograms for lung cancer: the Ulysses syndrome. Arch Intern Med. 1993;153:1933,1937.
44. Bailar JC III. Screening for lung cancer: where are we now? Am Rev Respir Dis. 1984;130:541-542.
45. Black WC, Welch HG. Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy. N Engl J Med. 1993; 328:1237-1243.
46. Catalona WJ. Screening for prostate cancer: enthusiasm. Urology. 1993;42:113-115.
47. Catalona WJ, Richie JP, Ahmann FR, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6630 men. J Urol. 1994;151:1283-1290.
48. Catalona WJ, Smith DS, Ratliff TL, Basler JW. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA. 1993;270:948-954.
49. Mettlin C, Murphy GP, Lee F, et al. Characteristics of prostate cancers detected in a multi-modality early detection program. Cancer. 1993; 72:1701-1708.
50. Prorok P. The National Cancer Institute Multi-Screening Trial. Con J Oncol. 1994;4(suppl):98-101.
51. Gohagan JK, Prorok PC, Kramer BS, Cornett JE. Prostate cancer screening in the prostate, lung, colorectal, and ovarian screening trial of the National Cancer Institute. J Urol. 1994;152:1905-1909.
52. Wilt TJ, Brawer MK. The Prostate Cancer Intervention Versus Observation Trial: a randomized trial comparing radical prostatectomy versus expectant management for the treatment of clinically localized prostate cancer. J Urol. 1994;152:1910-1914.
53. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA Cancer J Clin. 1996;46:5-27.
54. Lilienfeld A, Archer PG, Burnett CH, et al. An evaluation of radiologic and cytologic screening for the early detection of lung cancer: a cooperative pilot study of the American Cancer Society and the Veterans Administration. Cancer Res. 1966:26:2083-2121.
55. Ruckle HC, Klee GG, Oesterling JE. Prostate-specific antigen: critical issues for the practicing physician. Mayo Clin Proc. 1994;69:59-68.
56. Ritchie JP, Catalona WJ, Ahmann FR, et al. Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination. Urology. 1993;42:365-374.
57. Barry MJ, Fleming C, Coley CM, Wasson JH, Fahs MC, Oesterling JE. Should Medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? I: framing the debate. Urology. 1995;46:2-13.
58. Barry MJ, Fleming C, Coley CM, Wasson JH, Fahs MC, Oesterling JE. Should Medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? II: early detection strategies. Urology. 1995;46:125-141.
59. Barry MJ, Fleming C, Coley CM, Wasson JH, Fahs MC, Oesterling JE. Should Medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? III: management strategies and outcomes. Urology. 1995; 46:277-289.
60. Barry MJ, Fleming C, Coley CM, Wasson JH, Fahs MC, Oesterling JE. Should Medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? IV: estimating the risks and benefits of an early detection program. Urology. 1995;46:445-461.
61. Lederle FA, Niewoehner DE. Lung cancer surgery: a critical review of the evidence. Arch Intern Med. 1994;154:2397-2400.
62. Wasson JH, Cushman CC, Bruskewitz RC, Littenberg B, Mulley AG Jr, Wennberg JE. A structured literature review of treatment for localized prostate cancer. Arch Fam Med. 1993;2:487-493.
63. Brett AS. The mammography and prostate-specific antigen controversies: implications for patient-physician encounters and public policy. J Gen Intern Med. 1995;10:266-270.
64. Littrup PJ. Prostate cancer screening: appropriate choices? Cancer. 1994;74:2016-2022.
65. Hahn DL, Roberts RG. PSA screening for asymptomatic prostate cancer: truth in advertising. J Fam Pract. 1993;37:432-436.
66. Stone NN, DeAntoni EP, Crawford ED. Screening for prostate cancer by digital rectal examination and prostate-specific antigen: results of Prostate Cancer Awareness Week, 1989-1992. Urology. 1994;44:18-25.
67. US Preventive Services Task Force. Guide to Clinical Preventive Services: Screening for Prostate Cancer. Baltimore, Md: Williams & Wilkins; 1996:119-134.
68. Woolf SH. Current concepts: screening for prostate cancer with prostate-specific antigen: an examination of the evidence. N Engl J Med. 1995; 333:1401-1405.
69. Chodak GW. Questioning the value of screening for prostate cancer in asymptomatic men. Urology. 1993;42:116-118.
70. Chodak GW. Screening for prostate cancer in 1993: is it appropriate, or not? Semin Ural. 1993; 11:47-49.
71. Barry MB. Proving early detection and treatment of prostate cancer does more good than harm: the need to support randomized trials actively. J Urol. 1994;152:1903-1904.
72. Jacobsen SJ, Katusic SK, Bergstralh EJ, et al. Incidence of prostate cancer diagnosis in the eras before and after serum prostate-specific antigen testing. JAMA. 1995;274:1445-1449.
73. Potosky AL, Miller BA, Albertsen PC, Kramer BS. The role of increasing detection in the rising incidence of prostate cancer. JAMA. 1995;273:548-552.